# Edoxaban

## Lixiana FC 30mg

| 藥物代碼           | OLIX                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Deep vein thrombosis and pulmonary embolism: Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5 to 10 days of initial therapy with a parenteral anticoagulant.Nonvalvular atrial fibrillation: To reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF)                                                                                                                                                                                                                                                                    |
| 副作用             | >10%:Hematologic and oncologic: Hemorrhage (22%)1% to 10%:Dermatologic: Dermal hemorrhage (6%), skin rash (4%)Gastrointestinal: Gastrointestinal hemorrhage (4%), lower GI bleeding (3%)Genitourinary: Vaginal hemorrhage (9%), gross hematuria, urethral bleedingHematologic and oncologic: Major hemorrhage, nonlife-threatening (7% to 9%; noncritical organ: 1%; critical organ: <1%), major hemorrhage (1%), oral hemorrhage (3%), anemia (2%), decreased hemoglobin (1%), puncture site bleeding (1%)Hepatic: Abnormal hepatic function tests (5% to 8%)Respiratory: Epistaxis (5%), pharyngeal bleeding |
| 禁忌               | Active pathological bleeding, hypersenstive.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

